- CA$0.47m
- CA$1.53m
- CA$4.16m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.51 | 7.02 | 5.73 | 4.91 | 4.16 |
Cost of Revenue | |||||
Gross Profit | 3.71 | 3.16 | 2.41 | 2.31 | 2.27 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.63 | 7.06 | 6.42 | 5.71 | 5.08 |
Operating Profit | -0.119 | -0.039 | -0.691 | -0.797 | -0.925 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.375 | -0.189 | -0.782 | -0.745 | -1.01 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.061 | -0.193 | -0.784 | -0.745 | -1.01 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.061 | -0.193 | -0.784 | -0.745 | -1.01 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.061 | -0.193 | -0.784 | -0.745 | -1.01 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.026 | -0.074 | -0.033 | -0.032 | -0.043 |